A Rhode Island businessman has admitted to running a scheme to sell mislabeled drugs, including those used to treat cancer.
Arif Diwan pleaded guilty Monday in federal court in Providence to conspiracy to engage in false labeling of pre-retail medical products and related crimes.
Diwan ran Lifescreen LLC, a Cranston-based company that sold drugs under the brand name LifeLogic. Between 2012 and 2015, Diwan filled numerous orders for high-cost pharmaceutical products, including a number of cancer treatment products.
Prosecutors say he rebranded and relabeled drugs manufactured in India, adding bogus Federal Drug Administration codes to make it appear the drugs were manufactured in the United States or Europe and approved by the FDA. Diwan shipped the drugs to customers in numerous countries.
Diwan is scheduled to be sentenced Sept. 16.
A Rhode Island businessman has admitted to running a scheme to sell mislabeled drugs, including those used to treat cancer.
Arif Diwan pleaded guilty Monday in federal court in Providence to conspiracy to engage in false labeling of pre-retail medical products and related crimes.
Diwan ran Lifescreen LLC, a Cranston-based company that sold drugs under the brand name LifeLogic. Between 2012 and 2015, Diwan filled numerous orders for high-cost pharmaceutical products, including a number of cancer treatment products.
Prosecutors say he rebranded and relabeled drugs manufactured in India, adding bogus Federal Drug Administration codes to make it appear the drugs were manufactured in the United States or Europe and approved by the FDA. Diwan shipped the drugs to customers in numerous countries.
Diwan is scheduled to be sentenced Sept. 16.
A Rhode Island businessman has admitted to running a scheme to sell mislabeled drugs, including those used to treat cancer.
Arif Diwan pleaded guilty Monday in federal court in Providence to conspiracy to engage in false labeling of pre-retail medical products and related crimes.
Diwan ran Lifescreen LLC, a Cranston-based company that sold drugs under the brand name LifeLogic. Between 2012 and 2015, Diwan filled numerous orders for high-cost pharmaceutical products, including a number of cancer treatment products.
Prosecutors say he rebranded and relabeled drugs manufactured in India, adding bogus Federal Drug Administration codes to make it appear the drugs were manufactured in the United States or Europe and approved by the FDA. Diwan shipped the drugs to customers in numerous countries.
Diwan is scheduled to be sentenced Sept. 16.
